...
...
News / Topic / Bharat Biotech / News
[

bharat biotech news

]

Former ISRO, DRDO chairmen, two others appointed AP govt advisors

Sreedhara Panicker Somanath, who is currently a professor at the Vikram Sarabhai Space Centre, will hold the position for two years or until the need for the post ceases (HT Photo)
india news
Updated on Mar 20, 2025 05:05 PM IST

New vaccine to prevent lumpy skin disease in cattle gets govt approval

The vaccine got approval by the central drugs standard organisation (CDSCO). (Bharat Biotech | Official X account)
india news
Updated on Feb 10, 2025 05:05 PM IST

Bharat Biotech collaborates with US-based Alopexx to develop antimicrobial vaccine

Alopexx would be entitled to a one-time upfront payment and milestone payments, as well as royalties on future. (Representative file photo)
india news
Published on Sep 11, 2024 04:51 PM IST

ICMR distances itself from safety study on Covaxin

ICMR collaborated with Bharat Biotech on developing the inactivated vaccine. (Pratham Gokhale/HT Photo)
india news
Updated on May 21, 2024 12:19 AM IST

‘Safety is primary focus’: Covaxin-developer amid reports on AstraZeneca vaccine

Bharat Biotech, further said in its statement that Covaxin was evaluated in more than 27,000 subjects as part of its licensure process.
india news
Published on May 02, 2024 07:24 PM IST

Bharat Biotech starts TB vaccine’s trials in adults

Tuberculosis, which is transmitted through the respiratory tract, kills at least 1.6 million people and infects at least 10 million worldwide each year (AP)
india news
Updated on Mar 25, 2024 06:40 AM IST

Sudha Murty reacts after watching Vivek Agnihotri’s The Vaccine War

Sudha Murty at the screening of The Vaccine War with Pallavi Joshi and Vivek Agnihotri.
bollywood
Published on Sep 19, 2023 12:23 PM IST

Intranasal Covid-19 vaccine sees low response on Day 1

HT Image
mumbai news
Updated on Apr 28, 2023 11:52 PM IST

Amid Covid spike, Maharashtra to buy 2L vials of vaccine from Bharat Biotech

Covovax is the fourth Covid vaccine that has been approved for emergency use in the concerned age group. (AFP)
mumbai news
Published on Apr 18, 2023 07:46 AM IST

‘If India takes the Covid nasal vaccine, other countries will also use it’:

Bharat Biotech founder Krishna Ella. (ANI)
india news
Updated on Feb 06, 2023 04:35 AM IST

3 lakh intranasal Covid vaccine doses sent to hospitals: Bharat Biotech

3 lakh intranasal Covid vaccine doses sent to hospitals: Bharat Biotech
india news
Published on Feb 05, 2023 06:42 PM IST

India launches world’s 1st intranasal Covid vaccine: Check price, availability

Bharat Biotech Nasal vaccine prices revealed.
india news
Published on Jan 27, 2023 09:08 AM IST

Health minister Mandaviya launches Bharat Biotech's nasal Covid vaccine

The nasal vaccine -- BBV154 -- had received the Drugs Controller General of India's (DCGI) approval in November for restricted emergency use among adults as a heterologous booster dose.
india news
Published on Jan 26, 2023 03:53 PM IST

Covid: 250 million Corbevax, Covaxin in stock, ready for dispatch

Covid: 250 million Corbevax, Covaxin in stock, ready for dispatch.
india news
Updated on Dec 28, 2022 01:44 PM IST

Bharat Biotech reveals prices for nasal spray against Covid. Check here

A resident receives a nasal spray vaccine as booster dose against coronavirus disease (COVID-19). REUTERS
india news
Updated on Dec 27, 2022 03:06 PM IST

Bharat Biotech's intranasal vaccine cleared for ‘restricted emergency use’

An employee of Bharat Biotech speaks on a mobile phone inside a bus (AP Photo)
india news
Published on Nov 28, 2022 08:38 PM IST

Nasal vaccines could help control Covid, says WHO

WHO emergencies director Mike Ryan said nasal vaccines generated immune response in the respiratory mucosa in the lungs.
world news
Published on Sep 07, 2022 10:08 PM IST

India gets 1st Covid nasal vaccine | Things to know about Bharat Biotech’s jab

Bharat Biotech Covid Vaccine: Bharat Biotech’s Covid nasal vaccine has been approved.
india news
Published on Sep 06, 2022 07:12 PM IST

Bharat Biotech finishes trials for intranasal Covid vaccine

Bharat Biotech International Limited, makers of Covaxin vaccine, has completed the phase-III and booster dose trials for its intranasal Covid-19 vaccine BBV154, the company announced on Monday. (Hindustan Times)
india news
Updated on Aug 16, 2022 05:10 AM IST

Bharat Biotech ends intranasal Covid vaccine booster trials, says found safe

Bharat Biotech’s BBV154 is a recombinant replication-deficient adenovirus vectored vaccine with a pre-fusion stabilised spike protein. (File Photo: Hindustan Times)
india news
Updated on Aug 15, 2022 11:39 PM IST

Covid-19 travel update: Japan approves Covaxin booster dose for travellers

Covid-19 travel update: Japan approves Covaxin booster dose for travellers 
travel
Updated on Aug 06, 2022 06:31 PM IST

Bharat Biotech's Covid-19 nasal vaccine phase III trials completed

On the booster dose of Covid-19, Krishna said that those who had taken the second dose must take the booster dose.
india news
Updated on Jun 19, 2022 10:04 AM IST

Bharat Biotech on WHO's Covaxin supply suspension: No impact on efficacy, safety

Bharat Biotech said it is slowing down the production of Covaxin for pending facility maintenance and optimization activities.
india news
Updated on Apr 03, 2022 11:52 AM IST

WHO suspends Covaxin supplies under UN procurement

The World Health Organization (WHO) has suspended the supply of Bharat Biotech’s anti-Covid vaccine, Covaxin, under the Covax facility, the UN health body announced on Saturday. (HT PHOTO.)
india news
Updated on Apr 03, 2022 04:12 AM IST

Can’t disclose data on trials: Vaccine makers to Supreme Court

A student receives a dose of a Covid vaccine in Noida. (HT photo/Sunil Ghosh)
india news
Updated on Mar 23, 2022 05:04 AM IST

Received nod to hold Covaxin clinical trials in US: Bharat Biotech

On February 2 last year, Ocugen had also announced an exclusive licensing agreement with Bharat Biotech to obtain exclusive rights to develop, manufacture and commercialise Covaxin in the US. (HT File)
india news
Updated on Feb 20, 2022 12:52 AM IST

DCGI approves trials for internasal booster dose

The phase 3 trials will be conducted as randomised open label multi-center study to compare immunogenicity and safety of BBV154 with Covaxin. (File/Representative use)
india news
Published on Jan 29, 2022 04:45 AM IST

Bharat Biotech gets DGCI nod for intranasal Covid booster doses 

Representational image.
india news
Updated on Jan 28, 2022 03:30 PM IST

Bharat Biotech again urges health staff to be ‘vigilant’ while jabbing teenagers

A medic administers Covid vaccine to a teen in Ludhiana at the civil surgeon’s office. The vaccination drive for this group began on January 3. (HT Photo)
india news
Updated on Jan 18, 2022 08:39 PM IST

Covaxin booster shot neutralises Omicron, says Bharat Biotech

A booster shot of Covaxin is administered six months after the last of two doses.
india news
Published on Jan 12, 2022 07:10 PM IST
View more
Sign in
Sign out
Subscribe Now
Copyright © HT Digital Streams Ltd. All rights reserved.